CreoSalus Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CreoSalus's estimated annual revenue is currently $4.2M per year.(i)
  • CreoSalus's estimated revenue per employee is $155,000

Employee Data

  • CreoSalus has 27 Employees.(i)
  • CreoSalus grew their employee count by -7% last year.

CreoSalus's People

NameTitleEmail/Phone
1
Associate Director, Quality and ComplianceReveal Email/Phone
2
QC ManagerReveal Email/Phone
3
Assistant Manager QCReveal Email/Phone
4
Analytical SpecialistReveal Email/Phone
5
Human Resources, Executive Administrative Assistant, and FacilitiesReveal Email/Phone
6
Materials Management SpecialistReveal Email/Phone
7
Manufacturing ChemistReveal Email/Phone
8
Senior Quality Assurance SpecialistReveal Email/Phone
9
Manufacturing Peptide ChemistReveal Email/Phone
10
Quality Control ChemistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M10-29%N/AN/A
Add Company

What Is CreoSalus?

Biotech company

keywords:Healthcare,Pharmaceuticals

N/A

Total Funding

27

Number of Employees

$4.2M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CreoSalus News

2022-03-22 - Peptide Therapeutics: Contract API Manufacturing Market ...

... Constant Therapeutics; CordenPharma; Corvid Pharmaceuticals; Covalab; CPC Scientific; Creative Peptides; CreoSalus; CSBio; CureDM; Curia...

2022-03-22 - Peptide Therapeutics: Industry Trends and Global Forecasts ...

... Constant Therapeutics; CordenPharma; Corvid Pharmaceuticals; Covalab; CPC Scientific; Creative Peptides; CreoSalus; CSBio; CureDM; Curia...

2018-10-25 - Downtown Lexington skyline to look dramatically different as City Center nears completion – Lane Report | Kentucky Business & Economic News

... as well as a pharmaceutical manufacturing facility for CreoSalus in Louisville and Blue Grass Airport's new community hangar for the airport's ...

2018-03-29 - Synthesising Difficult Phosphopeptides

N,N'-Diisopropylcarbodiimide (DIC) was purchased from CreoSalus (Louisville, KY). Piperidine was obtained from Alfa Aesar (Ward Hill, MA).

2014-11-25 - United Technologies CIO Is Changing the Retirement Game

(Geisler left in 2010 to become COO and CFO at Creosalus, a Kentucky-based life-science company.) It was very hard to leave Verizon and its ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.6M270%N/A
#2
$2.8M2717%$11.6M
#3
$2.5M27-32%N/A
#4
$4.6M27-10%N/A
#5
$2.7M27N/AN/A